Status:
RECRUITING
Cortical-Basal Ganglia Speech Networks
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Parkinson Disease
Essential Tremor
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
In this research study the researchers want to learn more about brain activity related to speech perception and production.
Detailed Description
Speech production is disrupted in a number of neurological diseases that involve the basal ganglia, including Parkinson's disease (PD) and dystonia. The investigators will use a novel experimental app...
Eligibility Criteria
Inclusion
- Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease, essential tremor or dystonia.
- Subjects able to provide informed consent and comply with task instructions.
- Subjects 18-85 years old
Exclusion
- Subjects with reported hearing loss.
- Non-English-speaking subjects
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04286308
Start Date
October 1 2020
End Date
February 1 2026
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114